GYNAEHEALTH LIMITED

Company Registration Number:
07360460 (England and Wales)

Unaudited statutory accounts for the year ended 31 August 2024

Period of accounts

Start date: 01 September 2023

End date: 31 August 2024

GYNAEHEALTH LIMITED

Contents of the Financial Statements

for the Period Ended 31 August 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

GYNAEHEALTH LIMITED

Company Information

for the Period Ended 31 August 2024




Director: Jason Yap
Yen Lin Chan
Secretary: Jason Yap
Registered office: 14
Deer Park Road
Edgbaston
Birmingham
B16 0LX
Company Registration Number: 07360460 (England and Wales)

GYNAEHEALTH LIMITED

Directors' Report Period Ended 31 August 2024

The directors present their report with the financial statements of the company for the period ended 31 August 2024

Principal Activities

Healthcare and Consultancy Services

Political and charitable donations

No

Company policy on the employment of disabled persons

Not applicable

Directors

The directors shown below have held office during the whole of the period from 01 September 2023 to 31 August 2024
Jason Yap
Yen Lin Chan

Secretary
Jason Yap

This report was approved by the board of directors on 5 October 2024
And Signed On Behalf Of The Board By:

Name: Jason Yap
Status: Director

Name: Yen Lin Chan
Status: Director

GYNAEHEALTH LIMITED

Profit and Loss Account

for the Period Ended 31 August 2024


Notes

2024
£

2023
£
Turnover 201,802 36,596
Cost of sales ( 21,432 ) ( 1,139 )
Gross Profit or (Loss) 180,370 35,457
Income from coronavirus (COVID-19) business support grants 0 0
Distribution Costs ( 0 ) ( 0 )
Administrative Expenses ( 32,203 ) ( 16,268 )
Other operating income - 0
Operating Profit or (Loss) 148,167 19,189
Interest Receivable and Similar Income 0 0
Interest Payable and Similar Charges ( 815 ) ( 0 )
Profit or (Loss) Before Tax 147,352 19,189
Tax on Profit ( 17,460 ) ( 3,645 )
Profit or (Loss) for Period 129,892 15,544

The notes form part of these financial statements

GYNAEHEALTH LIMITED

Balance sheet

As at 31 August 2024


Notes

2024
£

2023
£
Fixed assets
Tangible assets: 4 54,548 200
Total fixed assets: 54,548 200
Current assets
Stocks: 0 0
Debtors: 5 0 0
Cash at bank and in hand: 95,538 15,200
Total current assets: 95,538 15,200
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 6 ( 7,167 ) ( 0 )
Net current assets (liabilities): 88,371 15,200
Total assets less current liabilities: 142,919 15,400
Creditors: amounts falling due after more than one year: 7 ( 7,167 ) ( 0 )
Provision for liabilities: ( 17,460 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 118,292 15,400

The notes form part of these financial statements

GYNAEHEALTH LIMITED

Balance sheet continued

As at 31 August 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 5 5
Revaluation reserve: 8 38,249 195
Profit and loss account: 80,038 15,200
Shareholders funds: 118,292 15,400

For the year ending 31 August 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 5 October 2024
And Signed On Behalf Of The Board By:

Name: Jason Yap
Status: Director

Name: Yen Lin Chan
Status: Director

The notes form part of these financial statements

GYNAEHEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

GYNAEHEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 0 0

GYNAEHEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

  • 3. Off balance sheet disclosure

    No

GYNAEHEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

4. Tangible assets

Land & buildings Office equipment Motor vehicles Total
Cost £ £ £ £
At 01 September 2023 - 200 0 200
Additions - 1,458 0 1,458
Disposals - - - -
Revaluations - ( 200 ) 53,090 52,890
Transfers - - - -
At 31 August 2024 - 1,458 53,090 54,548
Depreciation
At 01 September 2023 - - - -
Charge for year - - - -
On disposals - - - -
Other adjustments - - - -
At 31 August 2024 - - - -
Net book value
At 31 August 2024 - 1,458 53,090 54,548
At 31 August 2023 - 200 0 200

GYNAEHEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

5. Debtors


2024
£

2023
£
Trade debtors 0 0
Prepayments and accrued income 0 0
Other debtors 0 0
Total 0 0
Debtors due after more than one year: 0 0

GYNAEHEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

6.Creditors: amounts falling due within one year note


2024
£

2023
£
Bank loans and overdrafts 7,167 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 0 0
Accruals and deferred income 0 0
Other creditors 0 0
Total 7,167 0

GYNAEHEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

7.Creditors: amounts falling due after more than one year


2024
£

2023
£
Bank loans and overdrafts 7,167 0
Amounts due under finance leases and hire purchase contracts 0 0
Other creditors 0 0
Total 7,167 0

GYNAEHEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

8. Revaluation reserve


2024
£
Balance at 01 September 2023 195
Surplus or deficit after revaluation 38,054
Balance at 31 August 2024 38,249